Materiovigilance Programme of India: Current status and way forward

Postmarketing vigilance system for medical devices in India is not as vigorous as of drugs. W Materiovigilance involves post marketing surveillance of adverse events caused by medical devices. As per directive of WHO, many countries including India have established their own post marketing surveilla...

Descripción completa

Detalles Bibliográficos
Autores principales: Saifuddin, P. K., Tandon, Moksh, Kalaiselvan, Vivekanandan, Suroy, Benjamin, Pattanshetti, Vidya, Prakash, Ajay, Medhi, Bikash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396683/
https://www.ncbi.nlm.nih.gov/pubmed/35848694
http://dx.doi.org/10.4103/ijp.ijp_837_21
_version_ 1784771981445431296
author Saifuddin, P. K.
Tandon, Moksh
Kalaiselvan, Vivekanandan
Suroy, Benjamin
Pattanshetti, Vidya
Prakash, Ajay
Medhi, Bikash
author_facet Saifuddin, P. K.
Tandon, Moksh
Kalaiselvan, Vivekanandan
Suroy, Benjamin
Pattanshetti, Vidya
Prakash, Ajay
Medhi, Bikash
author_sort Saifuddin, P. K.
collection PubMed
description Postmarketing vigilance system for medical devices in India is not as vigorous as of drugs. W Materiovigilance involves post marketing surveillance of adverse events caused by medical devices. As per directive of WHO, many countries including India have established their own post marketing surveillance system. In India it is known as Materiovigilance Programme of India (MvPI). This article reviews the current state of MvPI, compares it with developed countries, identifies gaps, and recommends specific measure to strengthen the existing program.
format Online
Article
Text
id pubmed-9396683
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-93966832022-08-24 Materiovigilance Programme of India: Current status and way forward Saifuddin, P. K. Tandon, Moksh Kalaiselvan, Vivekanandan Suroy, Benjamin Pattanshetti, Vidya Prakash, Ajay Medhi, Bikash Indian J Pharmacol Short Communication Postmarketing vigilance system for medical devices in India is not as vigorous as of drugs. W Materiovigilance involves post marketing surveillance of adverse events caused by medical devices. As per directive of WHO, many countries including India have established their own post marketing surveillance system. In India it is known as Materiovigilance Programme of India (MvPI). This article reviews the current state of MvPI, compares it with developed countries, identifies gaps, and recommends specific measure to strengthen the existing program. Wolters Kluwer - Medknow 2022 2022-07-12 /pmc/articles/PMC9396683/ /pubmed/35848694 http://dx.doi.org/10.4103/ijp.ijp_837_21 Text en Copyright: © 2022 Indian Journal of Pharmacology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Short Communication
Saifuddin, P. K.
Tandon, Moksh
Kalaiselvan, Vivekanandan
Suroy, Benjamin
Pattanshetti, Vidya
Prakash, Ajay
Medhi, Bikash
Materiovigilance Programme of India: Current status and way forward
title Materiovigilance Programme of India: Current status and way forward
title_full Materiovigilance Programme of India: Current status and way forward
title_fullStr Materiovigilance Programme of India: Current status and way forward
title_full_unstemmed Materiovigilance Programme of India: Current status and way forward
title_short Materiovigilance Programme of India: Current status and way forward
title_sort materiovigilance programme of india: current status and way forward
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396683/
https://www.ncbi.nlm.nih.gov/pubmed/35848694
http://dx.doi.org/10.4103/ijp.ijp_837_21
work_keys_str_mv AT saifuddinpk materiovigilanceprogrammeofindiacurrentstatusandwayforward
AT tandonmoksh materiovigilanceprogrammeofindiacurrentstatusandwayforward
AT kalaiselvanvivekanandan materiovigilanceprogrammeofindiacurrentstatusandwayforward
AT suroybenjamin materiovigilanceprogrammeofindiacurrentstatusandwayforward
AT pattanshettividya materiovigilanceprogrammeofindiacurrentstatusandwayforward
AT prakashajay materiovigilanceprogrammeofindiacurrentstatusandwayforward
AT medhibikash materiovigilanceprogrammeofindiacurrentstatusandwayforward

Ejemplares similares